Pulmonary Tuberculosis
Showing 1 - 25 of 73
Pulmonary Tuberculosis, Gastro-Intestinal Disorder Trial in Rahim Yar Khan (Placebo, Zingier officinale powder, Carum carvi, L
Completed
- Pulmonary Tuberculosis
- Gastro-Intestinal Disorder
- Placebo
- +3 more
-
Rahim Yar Khan, Punjab, PakistanSheikh Zayed Medical / college
Dec 3, 2023
Pulmonary Tuberculosis Trial in Rio de Janeiro, Rio De Janeiro (Standard care plus pulmonary rehabilitation, Standard Care)
Recruiting
- Pulmonary Tuberculosis
- Standard care plus pulmonary rehabilitation
- Standard Care
-
Rio de Janeiro, Brazil
- +1 more
Nov 7, 2023
Hospitalized Pulmonary Tuberculosis at Strasbourg University
Recruiting
- Pulmonary Tuberculosis
-
Strasbourg, FranceCentre de Ressources et de Compétences de la Mucoviscidose (CRCM
Oct 25, 2023
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)
Not yet recruiting
- Pulmonary Tuberculosis
- Rifampicin-resistant Tuberculosis
- Bedaquiline
- +11 more
-
Beijing, Beijing, China
- +37 more
Oct 11, 2023
Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and
Not yet recruiting
- Pulmonary Tuberculosis
- Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
- +3 more
- (no location specified)
Jul 25, 2023
Pulmonary Tuberculosis Trial in Cape Town (Meropenem 6g IV over 6 hours, Ertapenem 1g IM, Meropenem 3g IV)
Completed
- Pulmonary Tuberculosis
- Meropenem 6g IV over 6 hours
- +9 more
-
Cape Town, Western Cape, South AfricaTASK Clinical Research Centre
May 31, 2023
Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)
Recruiting
- Pulmonary Tuberculosis
- Other Specified Pulmonary Tuberculosis
- Sutezolid
- +6 more
-
Lambaréné, Gabon
- +7 more
Apr 17, 2023
based Point-of-care Tests for Targeted Screening for Active TB
Completed
- Pulmonary Tuberculosis
- Trans-Dot point-of-care test
-
Addis Ababa, Ethiopia
- +9 more
Jan 30, 2023
Progressive Fibrosing Interstitial Lung Disease, Lung Transplant, Cystic Fibrosis Trial in Edmonton (ADAMM- RSM Device)
Recruiting
- Progressive Fibrosing Interstitial Lung Disease
- +4 more
- ADAMM- RSM Device
-
Edmonton, Alberta, CanadaUniversity of Alberta
Dec 1, 2022
Infections and Infestations, Pulmonary Tuberculosis Trial in South Africa, Tanzania (Delpazolid, Bedaquiline, Delamanid,
Active, not recruiting
- Infections and Infestations
- Pulmonary Tuberculosis
- Delpazolid
- Bedaquiline, Delamanid, Moxifloxacin
-
Tembisa, Gauteng, South Africa
- +4 more
Sep 13, 2022
COVID-19, Pulmonary Tuberculosis Trial in China (Standard dosage inactivated vaccine, Double dosage inactivated vaccine)
Recruiting
- COVID-19
- Pulmonary Tuberculosis
- Standard dosage inactivated vaccine
- Double dosage inactivated vaccine
-
Huai'an, Jiangsu, China
- +5 more
Aug 12, 2022
Pulmonary Tuberculosis, Body Weight Changes, Motor Activity Trial (Rifampicin, Isoniazid, Pyrazinamide)
Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)
Recruiting
- Tuberculosis
- +2 more
- Isoniazid
- +4 more
-
Johannesburg, Gauteng, South AfricaTembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022
Interferon Gamma Injections in Drug-resistant Pulmonary
Recruiting
- Pulmonary Tuberculosis
-
Moscow, Russian FederationFSBI "NMIC FPI" of the Ministry of Health of Russia
May 31, 2022
Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)
Completed
- Pulmonary Tuberculosis
- PA-824
- +5 more
-
Cape Town, South AfricaUniversity of Cape Town Lung Institute
May 18, 2022
Pulmonary Tuberculosis Trial in Beijing (WX-081, Bedaquiline, Standard treatment)
Recruiting
- Pulmonary Tuberculosis
- WX-081
- +3 more
-
Beijing, Beijing, ChinaBeijing Chest Hospital affiliated to Capital Medical University
Dec 14, 2021
Development ofArtificial Intelligence System for Intelligent
Recruiting
- Artificial Intelligence
- +7 more
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Nov 15, 2021
Tuberculosis, Pulmonary Tuberculosis Trial in Johannesburg (Pravastatin, Rifafour, Vitamin B6)
Recruiting
- Tuberculosis
- Pulmonary Tuberculosis
- Pravastatin
- +2 more
-
Johannesburg, Gauteng, South AfricaPHRU Non-Network CRS
Oct 29, 2021
Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South
Active, not recruiting
- Multi-drug Resistant Tuberculosis
- +2 more
- Bedaquiline
- +4 more
-
Minsk, Belarus
- +4 more
May 12, 2021
Pulmonary Tuberculosis Trial in Chennai (Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol)
Completed
- Pulmonary Tuberculosis
- Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol
-
Chennai, Tamilnadu, IndiaTuberculosis Research Centre
Apr 13, 2021
Pulmonary Tuberculosis Trial in Ysterplaat, Sydenham, Sandringham (Bedaquiline, PA-824, Linezolid)
Completed
- Pulmonary Tuberculosis
- Bedaquiline
- +2 more
-
Ysterplaat, Cape Town, South Africa
- +2 more
Nov 19, 2020
Pulmonary Tuberculosis, Diabetes, Type 2 Trial in Orizaba (Community intervention, Standard of care)
Withdrawn
- Pulmonary Tuberculosis
- Diabetes Mellitus, Type 2
- Community intervention
- Standard of care
-
Orizaba, Veracruz, MexicoCentro de Salud Camerino Mendoza
May 13, 2020